// App-Quantinova.ai

: Late Breaking Abstract - Reimbursement for asthma care is a universal barrier to achieving asthma symptom control: the SABINA III study

Researchers

Presenter

  • Eric D. Bateman

Principal Investigators

  • David B. Price

  • Hao-Chien Wang

  • Adel Khattab

  • Patricia Schonffeldt

  • Angelina Catanzariti

  • Ralf J.P. Van Der Valk

  • Maarten J.H.I. Beekman

Medical Centers

  • Division of Clinical Pharmacology, University of Cape Town, Cape Town, South Africa

  • Observational and Pragmatic Research Institute, Singapore, Singapore,

  • Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

  • Ain Shams Unversity, Cairo, Egypt

  • Especialista Medicina Interna y Enfermedades Respiratorias, Instituto Nacional del Tórax ITMS Telemedicina de Chile, Santiago, Chile

  • AstraZeneca, Sydney, Australia

  • Astra Zeneca, Cambridge, United Kingdom

  • AstraZeneca, The Hague, Netherlands

Locations

  • South Africa

  • Singapore

  • Taiwan

  • Egypt

  • Chile

  • Australia

  • United Kingdom

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved